BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 26552432)

  • 1. Benefits of an expanded use of plasma exchange for anti-neutrophil cytoplasmic antibody-associated vasculitis within a dedicated clinical service.
    Dhaun N; Saunders A; Bellamy CO; Gallardo RM; Manson L; Kluth DC
    BMC Musculoskelet Disord; 2015 Nov; 16():343. PubMed ID: 26552432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma Exchange Is Highly Effective for Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis Patients With Rapidly Progressive Glomerulonephritis Who Have Advanced to Dialysis Dependence: A Single-Center Case Series.
    Nishida R; Kaneko S; Usui J; Kawamura T; Tsunoda R; Tawara T; Fujita A; Nagai K; Kai H; Morito N; Saito C; Yamagata K
    Ther Apher Dial; 2019 Jun; 23(3):253-260. PubMed ID: 31033151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of severe renal disease in ANCA positive and negative small vessel vasculitis with rituximab.
    Shah S; Hruskova Z; Segelmark M; Morgan MD; Hogan J; Lee SK; Dale J; Harper L; Tesar V; Jayne DR; Geetha D
    Am J Nephrol; 2015; 41(4-5):296-301. PubMed ID: 26044574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early plasma exchange improves outcome in PR3-ANCA-positive renal vasculitis.
    Gregersen JW; Kristensen T; Krag SR; Birn H; Ivarsen P
    Clin Exp Rheumatol; 2012; 30(1 Suppl 70):S39-47. PubMed ID: 22510451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term outcome of patients with ANCA-associated vasculitis treated with plasma exchange: a retrospective, single-centre study.
    Frausová D; Hrušková Z; Lánská V; Lachmanová J; Tesař V
    Arthritis Res Ther; 2016 Jul; 18():168. PubMed ID: 27412443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recurrence of anti-neutrophil cytoplasmic antibody vasculitis in the kidney allograft.
    Lau D; Summers S; Amos L; Simpson I; Mulley W
    Nephrology (Carlton); 2012 Apr; 17 Suppl 1():16-9. PubMed ID: 22497649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous pulse methylprednisolone for induction of remission in severe ANCA associated Vasculitis: a multi-center retrospective cohort study.
    Chanouzas D; McGregor JAG; Nightingale P; Salama AD; Szpirt WM; Basu N; Morgan MD; Poulton CJ; Draibe JB; Krarup E; Dospinescu P; Dale JA; Pendergraft WF; Lee K; Egfjord M; Hogan SL; Harper L
    BMC Nephrol; 2019 Feb; 20(1):58. PubMed ID: 30777023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma exchange and glucocorticoid dosing for patients with ANCA-associated vasculitis: a clinical practice guideline.
    Zeng L; Walsh M; Guyatt GH; Siemieniuk RAC; Collister D; Booth M; Brown P; Farrar L; Farrar M; Firth T; Fussner LA; Kilian K; Little MA; Mavrakanas TA; Mustafa RA; Piram M; Stamp LK; Xiao Y; Lytvyn L; Agoritsas T; Vandvik PO; Mahr A
    BMJ; 2022 Feb; 376():e064597. PubMed ID: 35217581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Consideration of Therapeutic Plasma Exchange in Association With Inflammatory Lesions in ANCA-Associated Glomerulonephritis: A Real-World Retrospective Study From a Single Center.
    Tampe D; Ströbel P; Korsten P; Hakroush S; Tampe B
    Front Immunol; 2021; 12():645483. PubMed ID: 34220805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term outcome of severe alveolar haemorrhage in ANCA-associated vasculitis: a retrospective cohort study.
    Hruskova Z; Casian AL; Konopasek P; Svobodova B; Frausova D; Lanska V; Tesar V; Jayne DR
    Scand J Rheumatol; 2013; 42(3):211-4. PubMed ID: 23374071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal transplantation in anti-neutrophil cytoplasmic antibody-associated vasculitis.
    Hruskova Z; Geetha D; Tesar V
    Nephrol Dial Transplant; 2015 Apr; 30 Suppl 1():i159-63. PubMed ID: 25324359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term follow-up of patients with severe ANCA-associated vasculitis comparing plasma exchange to intravenous methylprednisolone treatment is unclear.
    Walsh M; Casian A; Flossmann O; Westman K; Höglund P; Pusey C; Jayne DR;
    Kidney Int; 2013 Aug; 84(2):397-402. PubMed ID: 23615499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rituximab for remission maintenance in relapsing antineutrophil cytoplasmic antibody-associated vasculitis.
    Smith RM; Jones RB; Guerry MJ; Laurino S; Catapano F; Chaudhry A; Smith KG; Jayne DR
    Arthritis Rheum; 2012 Nov; 64(11):3760-9. PubMed ID: 22729997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Case report: de novo ANCA-associated vasculitis after kidney transplantation treated with rituximab and plasma exchange.
    Sagmeister MS; Weiss M; Eichhorn P; Habicht A; Habersetzer R; Fischereder M; Schönermarck U
    BMC Nephrol; 2018 Oct; 19(1):270. PubMed ID: 30340563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Disease Activity at Three and Six Months After Diagnosis on Long-Term Outcomes in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
    Gopaluni S; Flossmann O; Little MA; O'Hara P; Bekker P; Jayne D;
    Arthritis Rheumatol; 2019 May; 71(5):784-791. PubMed ID: 30418705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis: 2-year results of a randomised trial.
    Jones RB; Furuta S; Tervaert JW; Hauser T; Luqmani R; Morgan MD; Peh CA; Savage CO; Segelmark M; Tesar V; van Paassen P; Walsh M; Westman K; Jayne DR;
    Ann Rheum Dis; 2015 Jun; 74(6):1178-82. PubMed ID: 25739829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conventional induction and maintenance treatment of Antineutrophil cytoplasmic antibodies-associated vasculitis - still of value for our patients?
    Tesar V; Hruskova Z
    Expert Opin Pharmacother; 2015; 16(11):1683-702. PubMed ID: 26149512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical implication of plasma exchange on life-threatening antineutrophil cytoplasmic antibody-associated vasculitis.
    Park PG; Yoo BW; Song JJ; Park YB; Lee SW
    BMC Pulm Med; 2020 May; 20(1):147. PubMed ID: 32466756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rituximab in the treatment of anti-neutrophil cytoplasm antibody-associated vasculitis.
    Jones RB
    Nephron Clin Pract; 2014; 128(3-4):243-9. PubMed ID: 25401382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variation in the Treatment of Children Hospitalized With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis in the US.
    James KE; Xiao R; Merkel PA; Weiss PF
    Arthritis Care Res (Hoboken); 2017 Sep; 69(9):1377-1383. PubMed ID: 27813340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.